ESAB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
ESAB Corp is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available. While the company has positive growth prospects and hedge fund interest, the technical indicators are weak, financial performance shows declining profitability, and insider selling raises concerns. It is better to hold off on investing right now and monitor the stock for better entry points.
The MACD histogram is -1.291, below 0, and negatively expanding, indicating bearish momentum. RSI is at 36.23, in the neutral zone, with no clear signal. Moving averages are converging, suggesting indecision in the market. Key support is at $123.345, and resistance is at $135.447. The stock closed at $124.87, close to its support level, but there is no strong bullish signal.
Hedge funds are buying, with a 127,921.66% increase in buying activity over the last quarter.
Analysts have raised price targets recently, with Stifel and JPMorgan projecting targets of $158 and $153, respectively.
The acquisition of Eddyfi Technologies adds strategic value to ESAB's portfolio, enhancing its end-to-end solutions.
Insiders are selling heavily, with a 2,355.33% increase in selling activity over the last month.
Financial performance in Q4 2025 shows declining profitability, with net income down 29.35% YoY and EPS down 30.23% YoY.
The MACD and RSI indicators suggest bearish momentum, with no clear reversal signals.
The company plans to sell $7.72 million worth of its common stock, which could dilute shareholder value.
In Q4 2025, revenue increased by 7.49% YoY to $720.99 million. However, net income dropped by 29.35% YoY to $37.00 million, and EPS declined by 30.23% YoY to $0.60. Gross margin also fell by 7.14% YoY to 35.76%, indicating declining profitability despite revenue growth.
Analysts maintain a generally positive outlook on ESAB. Stifel raised the price target to $158, and JPMorgan raised it to $153, both maintaining Buy or Overweight ratings. However, there are concerns about near-term performance due to high leverage and fiscal 2026 guidance requiring significant acceleration post-Q1.
